SGLT2 inhibitors are nearly as effective as the ketogenic diet in mouse models for cancer by dropping ambient insulin levels.

“Well, let me address the sodium glucose co-transporter inhibitor first. Because that is almost as effective as the ketogenic diet in our mouse models. It keeps the glucose level not quite as low as the ketogenic diet, but pretty damn low. And the importance, of course, is in both cases, it brings the insulin. Ambient insulin in the serum drops dramatically.”